Oct 24, 2014 09:52 BST
Myriad Genetics Ltd
EndoPredict® is a multi-gene test for breast cancer patients. Using a specially developed procedure, it determines whether a given patient needs chemotherapy, or whether solely anti-hormonal therapy constitutes sufficient treatment. The method is based on analysis of tumour genes in combination with the classical prognostic factors of nodal status and tumour size.